<DOC>
	<DOC>NCT01114334</DOC>
	<brief_summary>The purpose of the study is to determine whether motivational interviewing with guideline-based medical management for depression will significantly improve time to depression recovery and increase the proportion of subjects in recovery compared to guideline-based medical management alone over 9 months.</brief_summary>
	<brief_title>Motivational Interviews for Depression in Primary Care</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>1. Women and men aged 18 or older presenting at one of the seven DHH study clinics with a new treatment episode for depression will be considered for the study. 2. The PHQ9 is used to define depression category with a sensitivity and specificity for MDD of at least 88%. Patients must have PHQ9≥10 to ensure sufficient severity to warrant intervention. 3. A new treatment episode is defined as no treatment with an antidepressant medication for emotional problems over the previous 90 days, nor evidencebased psychotherapy for depression. 4. The subjects must have major depression as determined by diagnostic schedule. 1. Receipt of an antidepressant medication in the previous 90 days other than a lowdose TCA for pain or Trazodone for sleep (e.g. amitriptyline ≤ 50 mg a day or Trazodone ≤ 100 mg at night). 2. Current interpersonal or cognitive behavioral psychotherapy that focuses on depression. 3. Female subjects who are either pregnant or nursing. 4. Subjects with drug or alcohol dependency or abuse (except for nicotine or caffeine) within the preceding 6 months. 5. High risk for suicide.\ 6. Inability to communicate in English. 7. No personal telephone or homeless. 8. Lifetime bipolar disorder. 9. Psychosis. 10. Subjects with a lifetime history of autism, mental retardation, or pervasive developmental disorders. 11. Subjects with uncorrected hypothyroidism or hyperthyroidism. 12. Serious, unstable illnesses including hepatic, renal, gastroenterologic, respiratory, cardiovascular (including ischemic heart disease), endocrinologic, neurologic, immunologic, or hematologic disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>